These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33910703)

  • 1. Blood transcriptomics as non-invasive marker for kidney transplant rejection.
    Van Loon E; Naesens M
    Nephrol Ther; 2021 Apr; 17S():S78-S82. PubMed ID: 33910703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the rate of progression of chronic renal transplant rejection using the proliferating cell nuclear antigen ].
    Simić-Ogrizović S; Starcević-Bozović A; Blagojević R; Radivojević D; Djkanović L
    Srp Arh Celok Lek; 2002; 130(5-6):159-64. PubMed ID: 12395435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study.
    Van Loon E; Gazut S; Yazdani S; Lerut E; de Loor H; Coemans M; Noël LH; Thorrez L; Van Lommel L; Schuit F; Sprangers B; Kuypers D; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    EBioMedicine; 2019 Aug; 46():463-472. PubMed ID: 31378695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
    Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
    Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.
    Friedewald JJ; Kurian SM; Heilman RL; Whisenant TC; Poggio ED; Marsh C; Baliga P; Odim J; Brown MM; Ikle DN; Armstrong BD; Charette JI; Brietigam SS; Sustento-Reodica N; Zhao L; Kandpal M; Salomon DR; Abecassis MM;
    Am J Transplant; 2019 Jan; 19(1):98-109. PubMed ID: 29985559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome.
    Chamoun B; Caraben A; Torres IB; Sellares J; Jiménez R; Toapanta N; Cidraque I; Gabaldon A; Perelló M; Gonzalo R; O'Valle F; Moreso F; Serón D
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences.
    Stock KF; Klein BS; Cong MT; Regenbogen C; Kemmner S; Büttner M; Wagenpfeil S; Matevossian E; Renders L; Heemann U; Küchle C
    Clin Hemorheol Microcirc; 2011; 49(1-4):527-35. PubMed ID: 22214724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction.
    Quaglia M; Merlotti G; Guglielmetti G; Castellano G; Cantaluppi V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
    Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
    J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies.
    Eikmans M; Gielis EM; Ledeganck KJ; Yang J; Abramowicz D; Claas FFJ
    Front Med (Lausanne); 2018; 5():358. PubMed ID: 30671435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of rejection in kidney transplantation.
    Singh N; Samant H; Hawxby A; Samaniego MD
    Curr Opin Organ Transplant; 2019 Feb; 24(1):103-110. PubMed ID: 30540576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Markers for Transplant Rejection.
    Argani H
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):1-9. PubMed ID: 32008484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and risks of protocol biopsies in pediatric renal transplantation.
    Gordillo R; Munshi R; Monroe EJ; Shivaram GM; Smith JM
    Pediatr Nephrol; 2019 Apr; 34(4):593-598. PubMed ID: 29725772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation.
    Zarinsefat A; Guerra JMA; Sigdel T; Damm I; Sarwal R; Chan-On C; Szabo G; Aguilar-Frasco JL; Ixtlapale-Carmona X; Salinas-Ramos C; Ramirez-Martinez L; Ramirez C; Vilatoba M; Morales Buenrostro LE; Alberu JM; Sarwal MM
    Front Immunol; 2020; 11():614343. PubMed ID: 33613539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Rejection-Specific Genes in Peripheral Blood and Allograft Biopsy From Kidney Transplant.
    Meng H; Liang Y; Hao J; Lu J
    Transplant Proc; 2018; 50(1):115-123. PubMed ID: 29407293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A urinary metabolite constellation to detect acute rejection in kidney allografts.
    Banas MC; Neumann S; Pagel P; Putz FJ; Krämer BK; Böhmig GA; Eiglsperger J; Schiffer E; Ruemmele P; Banas B
    EBioMedicine; 2019 Oct; 48():505-512. PubMed ID: 31648995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Biomarkers in Kidney Transplantation.
    Yatim KM; Azzi JR
    Semin Nephrol; 2022 Jan; 42(1):2-13. PubMed ID: 35618393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients.
    van Ham SM; Heutinck KM; Jorritsma T; Bemelman FJ; Strik MC; Vos W; Muris JJ; Florquin S; Ten Berge IJ; Rowshani AT
    Kidney Int; 2010 Nov; 78(10):1033-40. PubMed ID: 20720522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.